Closing the book on Category II: time for individualized regimens for patients with recurrent tuberculosis
- PMID: 30236175
- PMCID: PMC6385594
- DOI: 10.5588/ijtld.18.0569
Closing the book on Category II: time for individualized regimens for patients with recurrent tuberculosis
Conflict of interest statement
Conflicts of interest: none declared.
Comment on
-
A systematic review of clinical outcomes on the WHO Category II retreatment regimen for tuberculosis.Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1127-1134. doi: 10.5588/ijtld.17.0705. Int J Tuberc Lung Dis. 2018. PMID: 30236179 Free PMC article.
References
-
- Murray JF, Schraufnagel DE, Hopewell PC. Treatment of tuberculosis. A historical perspective. Ann Am Thorac Soc 2015; 12: 1749–1759. - PubMed
-
- Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1979; 119: 579–585. - PubMed
-
- World Health Organization. Treatment of tuberculosis: guidelines for national programs 2nd ed. WHO/TB/97.220. Geneva, Switzerland: WHO, 1997.
-
- Iseman MD Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993; 329: 784–791. - PubMed
-
- National Center for HIV/AIDS VH, STD, and TB Prevention. Core Curriculum on Tuberculosis: what the clinician should know. 6th ed. Atlanta, GA, USA: Centers for Disease Control and Prevention, 2013.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
